Skip to main content
. Author manuscript; available in PMC: 2013 Feb 21.
Published in final edited form as: Mucosal Immunol. 2010 May 19;3(5):425–442. doi: 10.1038/mi.2010.26

Table 1. Ocular surface autoimmune diseases.

Ocular surface autoimmune disease Target tissue Immunopathological features
Localized disease
 Dry Eye Ocular surface epithelium Increased proinflammatory cytokines (e.g., IL- 1β, TNF-α, IL-17, IFN-γ); CD4+ T-cell infiltration within the conjunctiva; goblet cell loss; squamous metaplasia
 Mooren's ulcerative keratitis Corneal and conjunctival epithelium, Sclera Infiltration of neutrophils, plasma cells, lymphocytes, and eosinophils
Systemic autoimmunity
 Sjogren's syndrome Primary: lacrimal gland, ocular surface goblet cells CD4+ T-cell and B-cell infiltration, autoantibodies; goblet cell loss; squamous metaplasia
Secondary: similar features associated with example rheumatoid arthritis
 Ocular cicatricial pemphigoid Basement membrane of epithelium Autoantibody and complement deposition in basement membrane of the conjunctiva; macrophages and B cells in the stroma; fibrosis and scarring
 Stevens–Johnson syndrome Epithelium: mucosa and skin T-cell infiltration (CD4+, CD8+), NK cells; epithelial cell apoptosis; fibrosis; scarring; opacification of the cornea
Systemic autoimmunity following allograft
 Graft vs. host disease Skin, mucous membranes, eye (e.g., conjunctiva, lacrimal gland) T-cell infiltration; ocular surface manifestations include Dry Eye, KCS, pseudomembranous conjunctivitis, conjunctival fibrosis, lacrimal, and meibomian gland disease, corneal epithelial sloughing

Abbreviations: IFN, interferon; IL, interleukin; KCS, keratoconjunctivitis sicca; TNF, tumor necrosis factor.